Press Releases

Seattle, WA - Jan 27, 2016

Benaroya Research Institute Welcomes New Board Member for 2016

Benaroya Research Institute at Virginia Mason (BRI) announced a new member to its Board of Directors: Jeffrey Wortley

Jeffrey Wortley is Market Manager for Key Private Banking Seattle-Cascade offices. He provides customized financial strategies to meet the long term goals of families, business owners and nonprofit organizations. Wortley has more than 25 years’ experience in the financial services industry. He was previously a wealth management consultant with UBS working with clients throughout the Pacific Northwest. He is currently a member of the Seattle Estate Planning Council and Finance Co-Chair for the Seattle Chamber of Commerce.

Blog Main Image - BRI Building Rear

About Benaroya Research Institute

Benaroya Research Institute (BRI) is a world leader in human immune system research. BRI works to advance the science that will predict, prevent, reverse and cure immune system diseases like allergies, asthma, cancer, COVID-19 and autoimmune diseases. BRI accelerates discovery through laboratory breakthroughs in immunology that are then translated to clinical therapies. We believe that a breakthrough in one immune system disease can lead to progress against them all, and work tirelessly toward our vision of a healthy immune system for everyone. BRI is a world-renowned independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle.

To learn more, visit and connect with us on Facebook, Instagram, Threads, LinkedIn, X and YouTube.